Copyright © 1999 by the European Society of Cardiology.
Risk factors for coronary heart disease and acute-phase proteins. A population-based study
a Clinical Trial Service Unit and Epidemiological Studies Unit, Radcliffe Infirmary, Oxford
b ICRF General Practice Research Group, Division of Public Health and Primary Care, Institute of Health Sciences, Oxford
c Department of Cardiology and Molecular Microbiology, Southampton University Medical School, Southampton
d Immunological Medicine Unit, Royal Postgraduate Medical School, London, U.K.
revised August 29, 1998; accepted September 2, 1998
Abstract
Aims Circulating levels of C-reactive protein and serum amyloid A protein increase markedly, and albumin levels fall, during the acute-phase response to tissue injury, infection and inflammation. Some acute-phase proteins have been associated with increased risks of coronary heart disease in long-term prospective studies. The aim of the present study was to determine whether circulating concentrations of C-reactive protein, albumin and serum amyloid A protein are correlated with one another, standard vascular risk factors, markers of persistent infection, or indicators of socio-economic status.
Methods and Results We report a cross-sectional study of 704 individuals without a history of coronary heart disease from five general practices in Bedfordshire, U.K. Plasma levels of C-reactive protein and serum amyloid A protein were strongly associated with each other (2P<0·00001) and inversely related to levels of serum albumin (2P<0·00001). There were highly significant associations of plasma C-reactive protein concentrations with cigarette smoking and obesity (2P<0·00001 for each). Serum albumin levels were strongly associated with blood pressure (2P<0·0001) and plasma lipids (2P<0·001), and concentrations of serum amyloid A protein were strongly correlated with obesity (2P<0·0001).
Conclusion Previously reported long-term prospective studies have found an increased risk of coronary heart disease of about 50% in people with raised baseline levels of plasma C-reactive protein or low albumin. The strong cross-sectional associations we have found between levels of these proteins with each other and with concentrations of serum amyloid A protein suggest that some underlying process related to inflammation is likely to be of relevance to the causation of disease. Further studies are needed to determine if the strong associations of plasma levels of C-reactive protein with cigarette smoking and obesity indicate that this particular protein can mediate some of the effects of those risk factors on coronary heart disease.
Key Words: Coronary heart disease, acute-phase proteins, C-reactive protein, albumin, serum amyloid A protein
f1 Correspondence: Dr J Danesh, CTSU, Radcliffe Infirmary, Oxford OX2 6HE, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. L. Petersen, A. L. Marsland, J. Flory, E. Votruba-Drzal, M. F. Muldoon, and S. B. Manuck Community Socioeconomic Status is Associated With Circulating Interleukin-6 and C-Reactive Protein Psychosom Med, July 1, 2008; 70(6): 646 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Rosvall, G Engstrom, L Janzon, G Berglund, and B Hedblad The role of low grade inflammation as measured by C-reactive protein levels in the explanation of socioeconomic differences in carotid atherosclerosis Eur J Public Health, August 1, 2007; 17(4): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, B. Hedblad, M. Rosvall, L. Janzon, and F. Lindgarde Occupation, Marital Status, and Low-Grade Inflammation: Mutual Confounding or Independent Cardiovascular Risk Factors? Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 643 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Ladwig, B. Marten-Mittag, H. Lowel, A. Doring, and W. Koenig C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998 Eur. Heart J., December 1, 2005; 26(23): 2537 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. McAdam, D. Byrne, J. D. Morrow, and J. A. Oates Contribution of Cyclooxygenase-2 to Elevated Biosynthesis of Thromboxane A2 and Prostacyclin in Cigarette Smokers Circulation, August 16, 2005; 112(7): 1024 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Hirschfield, J. R. Gallimore, M. C. Kahan, W. L. Hutchinson, C. A. Sabin, G. M. Benson, A. P. Dhillon, G. A. Tennent, and M. B. Pepys Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice PNAS, June 7, 2005; 102(23): 8309 - 8314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. MacCallum Markers of Hemostasis and Systemic Inflammation in Heart Disease and Atherosclerosis in Smokers Proceedings of the ATS, April 1, 2005; 2(1): 34 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yarnell, E. McCrum, A. Rumley, C. Patterson, V. Salomaa, G. Lowe, A. Evans, and on behalf of the MONICA Optional Haemostasis Study Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study{dagger} Eur. Heart J., February 2, 2005; 26(4): 332 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A S T Bickerton, N Clark, D Meeking, K M Shaw, M Crook, P Lumb, C Turner, and M H Cummings Cardiovascular risk in women with polycystic ovarian syndrome (PCOS) J. Clin. Pathol., February 1, 2005; 58(2): 151 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Sheehan, P M Kearney, S O Sullivan, C Mongan, E Kelly, and I J Perry Acute coronary syndrome and chronic infection in the Cork coronary care case-control study Heart, January 1, 2005; 91(1): 19 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.F. Wilson CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Ability of Inflammatory Markers to Predict Disease in Asymptomatic Patients: A Background Paper Circulation, December 21, 2004; 110(25): e568 - e571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P.M. de Maat, E. M. Bladbjerg, J. von Bornemann Hjelmborg, L. Bathum, J. Jespersen, and K. Christensen Genetic Influence on Inflammation Variables in the Elderly Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2168 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.D.O. Lowe, P.M. Sweetnam, J.W.G. Yarnell, A. Rumley, C. Rumley, D. Bainton, and Y. Ben-Shlomo C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease: The Caerphilly and Speedwell Studies Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1957 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Douglas, A. J. Taylor, and P. G. O'Malley Relationship Between Depression and C-Reactive Protein in a Screening Population Psychosom Med, September 1, 2004; 66(5): 679 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Greenfield, K. Samaras, A. B. Jenkins, P. J. Kelly, T. D. Spector, J. R. Gallimore, M. B. Pepys, and L. V. Campbell Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic Influences Circulation, June 22, 2004; 109(24): 3022 - 3028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sajadieh, O. W. Nielsen, V. Rasmussen, H. O. Hein, S. Abedini, and J. F. Hansen Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease Eur. Heart J., March 1, 2004; 25(5): 363 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Johnson, K. E. Kip, O. C. Marroquin, P. M Ridker, S. F. Kelsey, L. J. Shaw, C. J. Pepine, B. Sharaf, C. N. Bairey Merz, G. Sopko, et al. Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation, February 17, 2004; 109(6): 726 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. MacGregor, J. R. Gallimore, T. D. Spector, and M. B. Pepys Genetic Effects on Baseline Values of C-Reactive Protein and Serum Amyloid A Protein: A Comparison of Monozygotic and Dizygotic Twins Clin. Chem., January 1, 2004; 50(1): 130 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.M. Hirschfield and M.B. Pepys C-reactive protein and cardiovascular disease: new insights from an old molecule QJM, November 1, 2003; 96(11): 793 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Brull, N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D.O. Lowe, M.J. World, S.E. Humphries, et al. Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2063 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kleemann, H. M.G. Princen, J. J. Emeis, J. W. Jukema, R. D. Fontijn, A. J.G. Horrevoets, T. Kooistra, and L. M. Havekes Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol-Lowering Effect in APOE*3-Leiden Transgenic Mice: Evidence for Antiinflammatory Effects of Rosuvastatin Circulation, September 16, 2003; 108(11): 1368 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Jousilahti, V Salomaa, V Rasi, E Vahtera, and T Palosuo Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status J. Epidemiol. Community Health, September 1, 2003; 57(9): 730 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Ledue and N. Rifai Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment Clin. Chem., August 1, 2003; 49(8): 1258 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Frohlich, M. Sund, H. Lowel, A. Imhof, A. Hoffmeister, and W. Koenig Independent association of various smoking characteristics with markers of systemic inflammation in men: Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95) Eur. Heart J., July 2, 2003; 24(14): 1365 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Thorand, H. Lowel, A. Schneider, H. Kolb, C. Meisinger, M. Frohlich, and W. Koenig C-Reactive Protein as a Predictor for Incident Diabetes Mellitus Among Middle-aged Men: Results From the MONICA Augsburg Cohort Study, 1984-1998 Arch Intern Med, January 13, 2003; 163(1): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.H. Whincup, J. Danesh, M. Walker, L. Lennon, A. Thomson, P. Appleby, A. Rumley, and G.D.O. Lowe von Willebrand factor and coronary heart disease. Prospective study and meta-analysis Eur. Heart J., November 2, 2002; 23(22): 1764 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Erlinger, E. Guallar, E. R. Miller III, R. Stolzenberg-Solomon, and L. J. Appel Relationship Between Systemic Markers of Inflammation and Serum {beta}-Carotene Levels Arch Intern Med, August 13, 2001; 161(15): 1903 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Chambers, S. Eda, P. Bassett, Y. Karim, S. G. Thompson, J. R. Gallimore, M. B. Pepys, and J. S. Kooner C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites Circulation, July 10, 2001; 104(2): 145 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamada, T. Gotoh, Y. Nakashima, K. Kayaba, S. Ishikawa, N. Nago, Y. Nakamura, Y. Itoh, and E. Kajii Distribution of Serum C-Reactive Protein and Its Association with Atherosclerotic Risk Factors in a Japanese Population : Jichi Medical School Cohort Study Am. J. Epidemiol., June 15, 2001; 153(12): 1183 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. O. Lowe, J. W. G. Yarnell, A. Rumley, D. Bainton, and P. M. Sweetnam C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study : Are Inflammation and Fibrin Turnover Linked in Pathogenesis? Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 603 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Packard, D. S.J. O'Reilly, M. J. Caslake, A. D. McMahon, I. Ford, J. Cooney, C. H. Macphee, K. E. Suckling, M. Krishna, F. E. Wilkinson, et al. Lipoprotein-Associated Phospholipase A2 as an Independent Predictor of Coronary Heart Disease N. Engl. J. Med., October 19, 2000; 343(16): 1148 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Danesh and M.B. Pepys C-reactive protein in healthy and in sick populations Eur. Heart J., October 1, 2000; 21(19): 1564 - 1565. [PDF]
|
|
|
|
|
|
E. Rapaport Erythrocyte sedimentation rate: is it a useful risk marker for coronary heart disease? Eur. Heart J., October 1, 2000; 21(19): 1567 - 1569. [PDF]
|
|
|
|
|
|
X. Garcia-Moll, E. Zouridakis, D. Cole, and J.C. Kaski C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men Eur. Heart J., October 1, 2000; 21(19): 1598 - 1606. [Abstract] [PDF]
|
|
|
|
|
|
W. L. Hutchinson, W. Koenig, M. Frohlich, M. Sund, G. D.O. Lowe, and M. B. Pepys Immunoradiometric Assay of Circulating C-Reactive Protein: Age-related Values in the Adult General Population Clin. Chem., July 1, 2000; 46(7): 934 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Whincup, J. Danesh, M. Walker, L. Lennon, A. Thomson, P. Appleby, C. Hawkey, and J. Atherton Prospective Study of Potentially Virulent Strains of Helicobacter pylori and Coronary Heart Disease in Middle-Aged Men Circulation, April 11, 2000; 101(14): 1647 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danesh Smoldering Arteries?: Low-grade Inflammation and Coronary Heart Disease JAMA, December 8, 1999; 282(22): 2169 - 2171. [Full Text] [PDF]
|
|